Stay updated on Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page.

Latest updates to the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRemoved key study documents and metadata from the record, including PDFs and location/arm information, thereby altering the materials and context available for the long-term extension study.SummaryDifference18%

- Check19 days agoChange DetectedThe page's underlying platform version was upgraded from v3.6.6 to v3.7.0, representing a software update.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page’s revision label was updated to v3.6.6, signaling a new revision of the study record.SummaryDifference0.0%

- Check54 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, indicating a minor maintenance update to the page's version. The change does not modify the study details or display content.SummaryDifference0.0%

- Check69 days agoChange DetectedA location entry for Zaporizhzhya, Ukraine, 69600 was added and the Zaporizhzhia, Ukraine, 69600 entry was removed to correct the city spelling in the site listings. The page revision was updated from v3.6.3 to v3.6.4.SummaryDifference0.1%

- Check90 days agoChange DetectedPage revision updated from v3.6.2 to v3.6.3, indicating a version bump in the page's content management. This change does not modify study data or public study details.SummaryDifference0.0%

Stay in the know with updates to Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page.